Literature DB >> 28756595

Structural and functional assessment after intravitreal injection of ranibizumab in diabetic macular edema.

YuDong Fu1, Ping Wang2, XuXia Meng1, Zhaodong Du1, DaBo Wang3.   

Abstract

PURPOSE: To evaluate structure and function improvement in central retina by optical coherence tomography (OCT) and multifocal electroretinography (mf-ERG) in diabetic macular edema (DME) patients after intravitreal injection of ranibizumab (IVR) treatment.
METHODS: Twenty-seven eyes in 27 patients with DME received three consecutive monthly injections of IVR (0.05 ml, 10 mg/ml) and as needed thereafter. The clinical parameters of best-corrected visual acuity (BCVA), central foveal thickness (CFT) and mf-ERG were monitored for 6 months before and after IVR. The findings at baseline, 1, 3 and 6 months were analyzed. Correlation and regression analyses were performed on BCVA, CFT, mf-ERG amplitude and implicit time of the N1 and P1 waves.
RESULTS: IVR significantly improved visual acuity from the beginning of the treatment (P < 0.05). There were significant decreases in the CFT compared with the baseline after IVR (P < 0.05). The mean amplitude of P1 and N1 in the central ring at all examinations increased significantly compared with the baseline (P < 0.05). The mean P1 and N1 implicit times in the central ring were shortened, but not significantly (P > 0.05). There were significant correlations of BCVA with CFT, P1 and N1 amplitudes in the central retina (P < 0.05).
CONCLUSION: In addition to the improvement in BCVA and the reduction in CFT, IVR improved macular retinal function, as assessed by mf-ERG, in diabetic eyes. The combination of OCT and mf-ERG for macular evaluation may better assess DME.

Entities:  

Keywords:  Diabetic macular edema; Mf-ERG; OCT; Ranibizumab

Mesh:

Substances:

Year:  2017        PMID: 28756595     DOI: 10.1007/s10633-017-9604-z

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  26 in total

Review 1.  The multifocal electroretinogram.

Authors:  Donald C Hood; Jeffrey G Odel; Candice S Chen; Bryan J Winn
Journal:  J Neuroophthalmol       Date:  2003-09       Impact factor: 3.042

2.  Heterodyne Fourier domain optical coherence tomography for full range probing with high axial resolution.

Authors:  Adrian Bachmann; Rainer Leitgeb; Theo Lasser
Journal:  Opt Express       Date:  2006-02-20       Impact factor: 3.894

Review 3.  ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition).

Authors:  Donald C Hood; Michael Bach; Mitchell Brigell; David Keating; Mineo Kondo; Jonathan S Lyons; Michael F Marmor; Daphne L McCulloch; Anja M Palmowski-Wolfe
Journal:  Doc Ophthalmol       Date:  2011-10-30       Impact factor: 2.379

4.  Multifocal electroretinography and fluorescein angiography in retinal vein occlusion.

Authors:  Charlotte Hvarfner; Sten Andreasson; Jörgen Larsson
Journal:  Retina       Date:  2006-03       Impact factor: 4.256

5.  Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study.

Authors:  Peter A Campochiaro; David M Brown; Carl C Awh; S Young Lee; Sarah Gray; Namrata Saroj; Wendy Yee Murahashi; Roman G Rubio
Journal:  Ophthalmology       Date:  2011-06-29       Impact factor: 12.079

6.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Authors:  Paul Mitchell; Francesco Bandello; Ursula Schmidt-Erfurth; Gabriele E Lang; Pascale Massin; Reinier O Schlingemann; Florian Sutter; Christian Simader; Gabriela Burian; Ortrud Gerstner; Andreas Weichselberger
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

7.  Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

Authors:  Quan Dong Nguyen; David M Brown; Dennis M Marcus; David S Boyer; Sunil Patel; Leonard Feiner; Andrea Gibson; Judy Sy; Amy Chen Rundle; J Jill Hopkins; Roman G Rubio; Jason S Ehrlich
Journal:  Ophthalmology       Date:  2012-02-11       Impact factor: 12.079

8.  Early local functional changes in the human diabetic retina: a global flash multifocal electroretinogram study.

Authors:  Jenny C Y Lung; Peter G Swann; Henry H L Chan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-12       Impact factor: 3.117

9.  Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.

Authors:  David J Browning; Adam R Glassman; Lloyd Paul Aiello; Roy W Beck; David M Brown; Donald S Fong; Neil M Bressler; Ronald P Danis; James L Kinyoun; Quan Dong Nguyen; Abdhish R Bhavsar; Justin Gottlieb; Dante J Pieramici; Michael E Rauser; Rajendra S Apte; Jennifer I Lim; Päivi H Miskala
Journal:  Ophthalmology       Date:  2006-11-21       Impact factor: 12.079

Review 10.  Vascular endothelial growth factor: basic science and clinical progress.

Authors:  Napoleone Ferrara
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

View more
  3 in total

1.  Long-term full-field and multifocal electroretinographic changes after treatment with ranibizumab in patients with diabetic macular edema.

Authors:  Kenan Yigit; Ümit Übeyt Inan; Sibel Inan; Mustafa Dogan; Guliz Fatma Yavas; Ersan Cetinkaya
Journal:  Int Ophthalmol       Date:  2021-01-23       Impact factor: 2.031

2.  Multifocal Electroretinogram Can Detect the Abnormal Retinal Change in Early Stage of type2 DM Patients without Apparent Diabetic Retinopathy.

Authors:  Jiang Huang; Yi Li; Yao Chen; Yuhong You; Tongtong Niu; Weijie Zou; Weifeng Luo
Journal:  J Diabetes Res       Date:  2021-02-23       Impact factor: 4.011

3.  Multifocal Electroretinogram Alterations after Intravitreal Ranibizumab Treatment in Diabetic Macular Edema.

Authors:  Sema Tamer Kaderli; Dicle Hazirolan; Guner Uney; Ahmet Kaderli; Nurten Unlu; Mehmet Akif Acar; Firdevs Ornek
Journal:  Beyoglu Eye J       Date:  2022-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.